SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001513162-20-000141
Filing Date
2020-07-20
Accepted
2020-07-20 09:00:11
Documents
1
Effectiveness Date
2020-07-20

Document Format Files

Seq Description Document Type Size
1 DEFA 14A defa14a.htm DEFA14A 48684
  Complete submission text file 0001513162-20-000141.txt   49859
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: DEFA14A | Act: 34 | File No.: 001-37492 | Film No.: 201035156
SIC: 2834 Pharmaceutical Preparations